Evidence-based guidelines for the pharmacological management of substance abuse, harmful use, addiction and comorbidity: recommendations from BAP

Journal of Psychopharmacology, 05/29/2012

The guidelines primarily cover the pharmacological management of withdrawal, short– and long–term substitution, maintenance of abstinence and prevention of complications, where appropriate, for substance abuse or harmful use or addiction as well management in pregnancy, comorbidity with psychiatric disorders and in younger and older people.

Print Article Summary Cat 2 CME Report